This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological and psychiatric disorders. Its structure, featuring a trifluoroethylamine moiety, is often incorporated into drug candidates to enhance metabolic stability and improve binding affinity to target receptors. It is also explored in the development of potential treatments for conditions like depression, anxiety, and neurodegenerative diseases due to its ability to modulate neurotransmitter systems. Additionally, it is used in preclinical studies to investigate its pharmacokinetic and pharmacodynamic properties.